SCHEMBL7420716

SCHEMBL7420716

CCCc1c(C(C)=O)c2ccc(C(=O)N(C)C)cc2n1Cc1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
DPP4 P27487 2/20 0.42
RORC P51449 1/20 0.39
S1PR3 Q99500 1/20 0.39
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
EGLN3 Q9H6Z9 1/20 0.36
PTGES O14684 1/20 0.36
TNF P01375 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150104 0.89 L3MBTL1 (0.47) L3MBTL1DPP4TP53ALDH1A1MEN1
SCHEMBL7421100 0.88 SLC22A12 (0.42) L3MBTL1DPP4RORCTP53ALDH1A1
SCHEMBL7424858 0.88 L3MBTL1 (0.47) L3MBTL1DPP4TP53ALDH1A1MEN1
SCHEMBL7418308 0.87 ALOX5AP (0.40) L3MBTL1DPP4TP53ALDH1A1MEN1
SCHEMBL7425821 0.86 L3MBTL1 (0.45) L3MBTL1DPP4S1PR3TP53ALDH1A1
SCHEMBL7418233 0.86 MAPT (0.42) L3MBTL1DPP4S1PR3TP53POLB
SCHEMBL7421179 0.84 L3MBTL1 (0.43) L3MBTL1DPP4TP53ALDH1A1MEN1
SCHEMBL7419326 0.83 SLC22A12 (0.45) L3MBTL1DPP4TP53ALDH1A1MEN1
SCHEMBL7422634 0.82 L3MBTL1 (0.42) L3MBTL1DPP4S1PR3TP53ALDH1A1
SCHEMBL7426692 0.82 ALOX5AP (0.43) L3MBTL1DPP4TP53ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed